Immuron (IMRN) Other Operating Expenses (2017 - 2024)
Immuron (IMRN) posted quarterly Other Operating Expenses of $48.5 billion for Q4 2024, up 6455318.51% year-over-year from N/an in Q1 2024, and up 262564868.32% quarter-over-quarter from $18452.7 in Q2 2024.
Immuron (IMRN) Other Operating Expenses (2017 - 2024) Analysis & Trends
Immuron's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $48.5 billion for Q4 2024.
- In Q4 2024, Other Operating Expenses rose 6455318.51% year-over-year to $48.5 billion; the TTM figure through Sep 2025 stood at $48.5 billion (up 6455318.51% YoY), while the FY2025 annual figure was $19775.7, up 7.69% from the prior year.
- Other Operating Expenses for Q4 2024 stood at $48.5 billion, up from $18452.7 in the prior quarter.
- The five-year high for Other Operating Expenses was $48.5 billion in Q4 2024, with the low at -$750560.0 in Q4 2023.
- The 5-year median for Other Operating Expenses is -$8736.3 (2020), against an average of $6.9 billion.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses sank 13689.24% in 2022, then jumped 6455318.51% in 2024.
- Immuron's Other Operating Expenses stood at -$8736.3 in 2020, then surged by 89.13% to -$949.56 in 2021, then tumbled by 13689.24% to -$130937.0 in 2022, then tumbled by 473.22% to -$750560.0 in 2023, then jumped by 6455318.51% to $48.5 billion in 2024.
- Business Quant data shows IMRN's Other Operating Expenses at $48.5 billion in Q4 2024, $18452.7 in Q2 2024, and -$750560.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 48.45 Bn |
| Jun 30, 2024 | 18,452.69 |
| Dec 31, 2023 | -750,560.00 |
| Jun 30, 2023 | -28,754.87 |
| Dec 31, 2022 | -130,937.00 |
| Dec 31, 2021 | -949.56 |
| Dec 31, 2020 | -8,736.33 |
| Dec 31, 2019 | 443.30 |
| Dec 31, 2018 | 257,501.00 |
| Dec 31, 2017 | -1.42 Mn |